in 3Q17. This was mostly due to an increase in revenues from Inpatients, Outpatients and IVF patients. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of Baht

million ( + 75% YoY, + 84% QoQ) , or earning per shares of THB 1. 35. The performance vastly improved mostly from the refinery business recorded high utilization rate and better GRM, as well as the power

price of oil products. Although, company total sales volume decreased 3% YoY, primarily due to decline in industrial market sales volume due to intensified competition, and the refinery’s TAM which

%GP at 22%, while 9M17 represented at 24%. Excluding TBSP of 17% GP, Company’s core %GP achieved at 25%, increased by 1%, primarily due to incremental of Gross Profit of Security business in 9M18 when

of Baht 638.12 million, a 22.02% improvement year-over-year from Baht 522.98 million in 2017. This was mostly due to an increase in revenues from Inpatients, Outpatients and opening of IVF Center. The

reported Revenues from hospital operations of Thai Baht 886.04 million, a 38.85% improvement year-over-year from Baht 638.12 million in 2018. This was mostly due to an increase in revenues from Inpatients

 200.01 million in 1Q19. This was mostly due to a decrease in revenues from  the epidemic of the coronary artery disease 2019 or Covid 19, affecting access to both inpatient and  outpatient services.  As

levels far below their agreed upon target by 150% during Q2/2018, which can mostly be attributed to reductions by Saudi Arabia, and production difficulties in Venezuela, as well as the US opting out of the

-6.3% 1.5% SSSG of Hardline segment -4.4% -0.1% SSSG of Food segment 1.1% 2.2% (1) Other income comprises revenue earned primarily from promotional, advertising income and logistics and distribution

primarily driven by the growth of rental rate with lower rental discounts in most projects, especially at CentralPlaza Chiangrai with double-digit rental growth after contract renewal, together with